Medical weight-care plan
A plan may include a health history review, body-mass and waist-risk review, medication history, sleep and stress screening, blood pressure review, glucose and cholesterol risk review, labs when clinically appropriate, nutrition goals, movement goals, and follow-up visits. Medication options are reviewed by generic name so patients understand the class, possible benefits, and safety questions to ask.
Metabolic review
Review weight history, blood pressure, A1C/glucose risk, cholesterol, thyroid concerns, sleep, medications, and family history.
Nutrition and movement
Build realistic protein, hydration, fiber, activity, sleep, and stress goals that match the patient's health status.
Medication discussion
Discuss whether FDA-approved medication options may be appropriate, including contraindications, side effects, access, cost, and follow-up.
Follow-up and maintenance
Track progress, side effects, labs, blood pressure, medication response, and a long-term maintenance plan.
Downloadable 7-day meal plans
These generic meal plans are designed as patient education tools for weight-care visits. They include the Florida Health Care of Brevard logo, a simple grocery list, daily meals, hydration reminders, and safety notes. Patients should review portions, calories, protein goals, allergies, diabetes needs, kidney or heart conditions, pregnancy status, and medications with the care team.
Branded printable plan with protein-focused meals, snacks, grocery list, and medical safety note.
Download7-Day Meal Plan for MenBranded printable plan with higher-protein meal ideas, snacks, grocery list, and medical safety note.
Meal plan note: These are general education plans, not individualized prescriptions. A clinician may adjust calories, protein, carbohydrates, sodium, fluids, and meal timing based on labs, medications, and medical history.
Basal metabolic rate calculator
Use this simple calculator to estimate basal metabolic rate, the number of calories your body may use at rest. This is a starting point for discussion with your care team, especially if you are using weight-care medication, have diabetes, thyroid disease, kidney disease, heart disease, or are pregnant.
BMR note: This calculator uses the Mifflin-St Jeor equation for adults. Actual needs vary based on muscle mass, medications, medical conditions, labs, and goals.
Medication options by generic name
Semaglutide
May help reduce appetite, improve fullness, support weight loss and maintenance in eligible patients, and may support cardiometabolic risk review. It is not right for everyone and requires medical screening.
Tirzepatide
Works on GIP and GLP-1 pathways and may reduce appetite and food intake. In FDA-reviewed trials, many patients achieved clinically meaningful weight reduction when combined with diet and activity.
Liraglutide
A daily injectable option that may support appetite control and weight management in eligible patients when paired with lifestyle changes and follow-up.
Phentermine / topiramate
May support appetite reduction and weight-loss maintenance for selected patients. It requires screening for blood pressure, heart history, pregnancy risk, medication interactions, and side effects.
Naltrexone / bupropion
May help some patients with cravings and eating behavior patterns. It requires careful review of blood pressure, seizure risk, mood history, opioid use, and other medicines.
Orlistat
Works in the digestive tract to reduce absorption of some dietary fat. Patients need counseling on gastrointestinal effects and fat-soluble vitamin timing.
Phentermine
May be used short term for selected patients when clinically appropriate. It requires review of heart history, blood pressure, stimulant sensitivity, and medication interactions.
Metformin and related review
Not a primary weight-loss drug for everyone, but may be discussed when insulin resistance, prediabetes, diabetes risk, or medication-related weight gain is part of the care picture.
Safety note: Medication decisions require an individual visit. Benefits, side effects, pregnancy considerations, thyroid cancer history, pancreatitis or gallbladder history, kidney function, diabetes medications, mood history, insurance coverage, and current drug shortages or availability should be reviewed with a clinician.
The future of GLP-1 and metabolic care
More personalized treatment
Weight care is moving toward matching treatment to metabolic risk, diabetes status, sleep apnea, heart risk, medication history, and patient goals instead of using one plan for everyone.
Combination pathways
Newer treatments are exploring multiple hormone pathways such as GLP-1, GIP, glucagon, amylin, and other appetite or energy-balance signals.
Oral and longer-acting options
Research continues on easier dosing, oral therapies, longer-acting medicines, and maintenance approaches after initial weight reduction.
Maintenance matters
The next phase of care is not only weight loss. It is maintaining progress, preserving muscle, monitoring labs, and reducing long-term health risk.
Helpful patient resources
Patient-friendly education on weight, nutrition, activity, and health risk.
MedlinePlusSemaglutideDrug information patients can review before asking questions at a visit.
MedlinePlusTirzepatideDrug information including uses, dosing concepts, and safety reminders.
FDATirzepatide approvalFDA summary of approval for chronic weight management in eligible adults.
Available across four Florida locations
- Palm Bay: 3255 Bayside Lakes Blvd, Suite 105
- Palm Coast: 57 Town CT, Suite 218
- Okeechobee: 3912 SE 18th Terrace
- Boynton Beach: 11082 S Military Trail